Αποτελέσματα Αναζήτησης
10 Ιαν 2024 · The purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings.
- ASCO Clinical Practice Guidelines | Journal of Clinical Oncology
Clinical practice guidelines serve as a guide for doctors...
- ASCO Clinical Practice Guidelines | Journal of Clinical Oncology
Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented).
METHODS A multidisciplinary, multinational panel reviewed existing ASCO guidelines and conducted modified ADAPTE and formal consensus processes. RESULTS Four published resource-agnostic guidelines were adapted for resource-constrained settings; informing two rounds of formal consensus; rec-ommendations received ≥75% agreement.
Systemic Treatment of Patients With Metastatic Breast Cancer Resource–Stratified Guideline January 10, 2024 Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
SELECTION OF OPTIMAL ADJUVANT CHEMOTHERAPY AND TARGETED THERAPY FOR EARLY BREAST CANCER: ASCO CLINICAL PRACTICE GUIDELINE FOCUSED UPDATE Recommendation Evidence Rating Patients with early-stage HER2-negative breast cancer with pathologic invasive residual disease at
The Expert Panel strongly advocates for a multidisciplinary team management approach when considering neoadjuvant therapy for patients with breast cancer. The guideline outlines recommendations based on clinical presentation, patient characteristics, and breast cancer subtype.
Introduction. The purpose of this guideline is to provide treatment recommendations for women with locally advanced and/or metastatic breast cancer who are being considered for treatment with chemotherapy and/or targeted therapy based on both a systematic review of the most recent evidence and on the incorporation of older data and reviews.
